These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 11007716)
1. High vesicular monoamine transporter binding in asymptomatic bipolar I disorder: sex differences and cognitive correlates. Zubieta JK; Huguelet P; Ohl LE; Koeppe RA; Kilbourn MR; Carr JM; Giordani BJ; Frey KA Am J Psychiatry; 2000 Oct; 157(10):1619-28. PubMed ID: 11007716 [TBL] [Abstract][Full Text] [Related]
2. Vesicular monoamine transporter concentrations in bipolar disorder type I, schizophrenia, and healthy subjects. Zubieta JK; Taylor SF; Huguelet P; Koeppe RA; Kilbourn MR; Frey KA Biol Psychiatry; 2001 Jan; 49(2):110-6. PubMed ID: 11164757 [TBL] [Abstract][Full Text] [Related]
3. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Frey KA; Koeppe RA; Kilbourn MR; Vander Borght TM; Albin RL; Gilman S; Kuhl DE Ann Neurol; 1996 Dec; 40(6):873-84. PubMed ID: 9007092 [TBL] [Abstract][Full Text] [Related]
4. Assessment of extrastriatal vesicular monoamine transporter binding site density using stereoisomers of [11C]dihydrotetrabenazine. Koeppe RA; Frey KA; Kuhl DE; Kilbourn MR J Cereb Blood Flow Metab; 1999 Dec; 19(12):1376-84. PubMed ID: 10598942 [TBL] [Abstract][Full Text] [Related]
5. Equilibrium versus compartmental analysis for assessment of the vesicular monoamine transporter using (+)-alpha-[11C]dihydrotetrabenazine (DTBZ) and positron emission tomography. Koeppe RA; Frey KA; Kume A; Albin R; Kilbourn MR; Kuhl DE J Cereb Blood Flow Metab; 1997 Sep; 17(9):919-31. PubMed ID: 9307605 [TBL] [Abstract][Full Text] [Related]
6. VMAT2 binding is elevated in dopa-responsive dystonia: visualizing empty vesicles by PET. De La Fuente-Fernández R; Furtado S; Guttman M; Furukawa Y; Lee CS; Calne DB; Ruth TJ; Stoessl AJ Synapse; 2003 Jul; 49(1):20-8. PubMed ID: 12710012 [TBL] [Abstract][Full Text] [Related]
7. In vivo measurement of the vesicular monoamine transporter in schizophrenia. Taylor SF; Koeppe RA; Tandon R; Zubieta JK; Frey KA Neuropsychopharmacology; 2000 Dec; 23(6):667-75. PubMed ID: 11063922 [TBL] [Abstract][Full Text] [Related]
8. Decreased striatal monoaminergic terminals in severe chronic alcoholism demonstrated with (+)[11C]dihydrotetrabenazine and positron emission tomography. Gilman S; Koeppe RA; Adams KM; Junck L; Kluin KJ; Johnson-Greene D; Martorello S; Heumann M; Bandekar R Ann Neurol; 1998 Sep; 44(3):326-33. PubMed ID: 9749598 [TBL] [Abstract][Full Text] [Related]
9. Decreased striatal monoaminergic terminals in olivopontocerebellar atrophy and multiple system atrophy demonstrated with positron emission tomography. Gilman S; Frey KA; Koeppe RA; Junck L; Little R; Vander Borght TM; Lohman M; Martorello S; Lee LC; Jewett DM; Kilbourn MR Ann Neurol; 1996 Dec; 40(6):885-92. PubMed ID: 9007093 [TBL] [Abstract][Full Text] [Related]
14. Increased platelet vesicular monoamine transporter density in adult schizophrenia patients. Zucker M; Valevski A; Weizman A; Rehavi M Eur Neuropsychopharmacol; 2002 Aug; 12(4):343-7. PubMed ID: 12126874 [TBL] [Abstract][Full Text] [Related]
15. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice. Kilbourn MR; Kuszpit K; Sherman P Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034 [TBL] [Abstract][Full Text] [Related]
16. Vesicular neurotransmitter transporters in Huntington's disease: initial observations and comparison with traditional synaptic markers. Suzuki M; Desmond TJ; Albin RL; Frey KA Synapse; 2001 Sep; 41(4):329-36. PubMed ID: 11494403 [TBL] [Abstract][Full Text] [Related]
17. Decreased platelet vesicular monoamine transporter density in habitual smokers. Schwartz K; Weizman A; Rehavi M Eur Neuropsychopharmacol; 2005 Mar; 15(2):235-8. PubMed ID: 15695071 [TBL] [Abstract][Full Text] [Related]
18. Binding of alpha-dihydrotetrabenazine to the vesicular monoamine transporter is stereospecific. Kilbourn M; Lee L; Vander Borght T; Jewett D; Frey K Eur J Pharmacol; 1995 May; 278(3):249-52. PubMed ID: 7589162 [TBL] [Abstract][Full Text] [Related]
19. Elevated platelet vesicular monoamine transporter density in untreated patients diagnosed with major depression. Zucker M; Aviv A; Shelef A; Weizman A; Rehavi M Psychiatry Res; 2002 Nov; 112(3):251-6. PubMed ID: 12450634 [TBL] [Abstract][Full Text] [Related]
20. Transient expression of the vesicular monoamine transporter during development in the rat thalamus and cortex. Leroux-Nicollet I; Costentin J Neurosci Lett; 1998 Jun; 248(3):167-70. PubMed ID: 9654335 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]